New study shows that higher frequency spinal cord stimulation is more effective for the treatment of chronic pain

New study shows that higher frequency spinal cord stimulation is more effective for the treatment of chronic pain

It has been estimated that 1 in 4 people in the US suffer from some form of chronic pain in their lifetime.  The duration of this pain differs from person to person, spanning several weeks to many years.

Many sufferers of long-term chronic pain can have their daily wellbeing severely affected if treatments fail to offer appropriate levels of pain relief.

Of the more than 1.5 billion people worldwide said to suffer from chronic pain, the most common area affected is the lower back.  The frequency of this is 23-26% of the global population.

Not surprisingly, this has been a hot area of research, which has produced treatment options from opioids to surgery.  Opioids, while very effective for analgesia, can produce unwanted long term problems like dependence for chronic pain patients.

For this reason, surgical options are frequently presented for long term chonic pain patients.  One such technique is spinal cord stimulation therapy (SCS), where pulses are delivered to the spinal cord by a small device implanted under the skin, emitting a form of paresthesia. As many as 50,000 patients in the US undergo SCS ever year to combat chronic pain.

Paresthesia is a sensation akin to tingling and is a result of SCS. When a device is turned on, an electrical current interrupts the pain signal being sent to the brain. Although a patient’s pain is not cured, SCS hopes to offer some temporarily relief.

Although SCS has been shown to reduce pain, many patients find the paresthesia that accompanies this to be uncomfortable.

This was to be the catalyst for scientists to develop a new form of SCS, one which still alleviates pain but reduces the effects of paresthesia in patients.

Traditional SCS uses frequencies of 40-60 hertz. Scientists decided to intensify this and use high-frequency pulses capable of delivering up to 10,000 hertzes. The new treatment has been named HF10.

Prof. Leonardo Kapural, lead study author and professor of anesthesiology at Wake Forest University School of Medicine and clinical director at Carolinas Pain Institute at Brookstown in Winston-Salem – both in North Carolina – believes the research to be the first of its kind.

“This is the first long-term study to compare the safety and effectiveness of high-frequency and traditional SCS therapy for back and leg pain,” he explains.

Scientists examined 171 patients with chronic back or leg pain, of whom 90 received HF10 therapy and 81 were treated with traditional SCS.

After 3 months, researchers found 85% of back pain and 83% of leg patients receiving HF10 therapy reported a 50% reduction in pain or greater. These patients also reported no experience of paresthesia.

In contrast, patients undergoing SCS reported less effective results. Only 44% of back pain patients and 56% leg patients experienced a minimum 50% reduction in pain.

The study ran over a 12-month period and found HF10 to be more effective compared with traditional SCS. More than half of the HF10 sample group reported being “very satisfied” with the outcome, compared with just 32% of patients who received traditional SCS.

Prof. Kapural hopes this research will be an important step toward treating chronic pain.

SCS represents an alternative for those patients who wish to avoid surgery or drugs such as opioids. According to a 2011 report, at least 100 million adult Americans suffer from chronic pain. In the same report, it was also estimated that chronic pain costs society between $500-635 billion a year.

Dr. Hanna has many years of experience performing SCS procedures for chronic pain patients.  To learn if this procedure might be right for you, please make an appointment with Dr. Hanna at the Florida Spine Institute in Clearwater, FL.  His contact information can be found here.

Stay Up to Date With the Latest Pain Research News!

Stay Up to Date With the Latest Pain Research News!

Weekly Breaking Research Updates

 

Scientific breakthroughs happen every day!  In an effort to help our patients stay up to speed on the most cutting edge treatment options available for them, our scientists monitor current research and publish weekly research updates.  The title of each article below is a link to the full study report.  If you’d like to make an appointment with Dr. Hanna to discuss your treatment options, please contact us.

 

Ketamine

 

Gender and estrous cycle influences on behavioral and neurochemical alterations in adult rats neonatally administered ketamine

VCM Borella, MV Seeman, RC Cordeiro… – Developmental …, 2015

Abstract Neonatal NMDA receptor blockade in rodents triggers schizophrenia-like

alterations during adult life. Schizophrenia is influenced by gender in age of onset,

premorbid functioning and course. Estrogen, the hormone potentially driving the gender

 

Hypothalamic, thalamic and hippocampal lesions in the mouse MCAO model: potential involvement of deep cerebral arteries?

M El Amki, T Clavier, N Perzo, R Bernard, PO Guichet… – Journal of Neuroscience …, 2015

Anesthetic methods in rodent models of cerebral ischemia impact the infarct volume. In

experimental models developed in rodents, the most used anesthetics are the volatile ones such

as isoflurane or halothane and intraperitoneal (ip) ketamine or barbiturates.

 

Targeting the CD80/CD86 costimulatory pathway with CTLA4‐Ig directs microglia toward a repair phenotype and promotes axonal outgrowth

A Louveau, V Nerrière‐Daguin, B Vanhove… – Glia, 2015

Male LEWIS 1A rats were anesthetized by intramuscular injection of 2% Rompun and 50mg/mL

ketamine (1.6 mL/kg) (PanPharma). Twenty-eight days after transplantation, grafted-male Lewis

1A rats were deeply anesthetized with Rompun-ketamine (1:4) at 1 mg/kg (ip).

 

[PDF] Anti-nociceptive effects of taurine and caffeine in sciatic nerve ligated wistar rats: involvement of autonomic receptors

W Abdulmajeed, BV Owoyele – Journal of African Association of Physiological …, 2015

(St. Louis MO, USA) while propranolol and prazosin were products of Namco

Chemicals, Amritsr, India. Normal saline and ketamine were purchased from Momrota

pharmacy, opposite University of Ilorin Teaching Hospital’s gate.

 

Two Cellular Hypotheses Explaining Ketamine’s Antidepressant Actions: Direct Inhibition and Disinhibition

OH Miller, JT Moran, BJ Hall – Neuropharmacology, 2015

Abstract A single, low dose of ketamine has antidepressant actions in depressed patients

and in patients with treatment-resistant depression (TRD). Unlike classic antidepressants,

which regulate monoamine neurotransmitter systems, ketamine is an antagonist of the N-

 

Effect of Piperine on Liver Function of CF-1 albino Mice.

JR Peela, SD Kolla, F Elshaari, F Elshaari, H El Awamy… – Infectious disorders drug …, 2015

with high fat diet. These mice were anaesthetized with ketamine and halothane and

blood was drawn from each mouse before the study and after three weeks by

cardiocentesis. Serum transaminases (alanine aminotransferase

 

[PDF] Correlation between anti-HBs and immunostimulatory cytokines following hepatitis B vaccination in mice

OU Peter, PO OKONKWO, OO John, A Dorathy – 2015

AM daily. All mice were acclimatized for two weeks. Diazepam injection (Valium,

Roche, USA), and ketamine injection (Ketalar, Popular Pharmaceuticals, Bangladesh)

were procured from Pax Pharmacy, Onitsha. Hepatitis B

 

Phosphodiesterase‐4D: an enzyme to remember

R Ricciarelli, E Fedele – British Journal of Pharmacology, 2015

enzyme isoform is localized in brain regions associated with emesis (eg area postrema and

nucleus of the solitary tract; Cherry and Davis, 1999; Lamontagne et al, 2001; Mori et al, 2010)

and its deletion in transgenic mice reduced the xylazine/ketamine-induced anaesthesia, a

 

The effects of tacrolimus on the activity and expression of tissue factor in the rat ovary with ischemia–reperfusion induced injury

UV Ustundag, S Sahin, K Ak, I Keskin… – Reproductive Biology, 2015

the ovaries. The rats were anesthetized with a combination of ketamine hydrochloride

(60 mg/kg ip.) and xylazine (5 mg/kg ip.). Supplementary injections of ketamine

hydrochloride were given when needed. After anesthesia

 

Novel Rat Model for Neurocysticercosis Using Taenia solium

MR Verastegui, A Mejia, T Clark, CM Gavidia… – The American Journal of …, 2015

Before intracranial inoculation, the rats were anesthetized with 70 mg/kg of ketamine plus

11 mg/kg of xylazine. Animals were euthanized after being anesthetized with a mixture of

100 mg/kg of ketamine, 10 mg/kg of xylazine, and 3 mg/kg of tramadol.

 

Photo of the Day: Low-dose Ketamine Infusions

A Katz – Emergency Medicine News, 2015

Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining

your privacy and will not share your personal information without your express consent. For more

information, please refer to our Privacy Policy. This blog serves as a bulletin board for

 

[HTML] Impact of Anesthesia Protocols on In Vivo Bioluminescent Bacteria Imaging Results

T Chuzel, V Sanchez, M Vandamme, S Martin, O Flety… – PLOS ONE, 2015

S. aureus Xen36 strain. Bioluminescence imaging was performed on mice

anesthetized by either ketamine/xylazine (with or without oxygen supplementation),

or isoflurane carried with air or oxygen. Total flux emission was

 

Sedative and Anxiolytic Agents

SI Ganzberg, S Wilson – Oral Sedation for Dental Procedures in Children, 2015

The salient fea- tures of nitrous oxide, chloral hydrate, meperidine, midazolam, antihista- mines,

and ketamine are discussed in relation to sedating children for dental procedures. Studies

using ketamine administered orally have resulted in mixed results.

 

[HTML] Fractionated Radiation Exposure of Rat Spinal Cords Leads to Latent Neuro-Inflammation in Brain, Cognitive Deficits, and Alterations in Apurinic Endonuclease 1

MAS Kumar, M Peluso, P Chaudhary, J Dhawan… – PLOS ONE, 2015

Ethics Statement. All exposures to radiation were done under ip anesthesia of xylazine/ ketamine

mixture- 4.3–5 ml per rat (male, Wistar strain) for an average weight of 540–600 gms (80 mg/kg

body weight of ketamine and 8 mg/ kg body weight of xylazine in PBS).

 

Combinations of dexmedetomidine and alfaxalone with butorphanol in cats: application of an innovative stepwise optimisation method to identify optimal clinical doses …

C Adami, T Imboden, AE Giovannini, C Spadavecchia – Journal of Feline Medicine …, 2015

anaesthesia. Commonly used protocols often include an a 2 -adrenoreceptor agonist

to produce reliable sedation, an opioid derivative to provide some analgesia, and

ketamine owing to its anaesthetic and analgesic effects.

 

[HTML] Development of Animal Models of Local Retinal DegenerationAnimal Models of Local Retinal Degeneration

H Lorach, J Kung, C Beier, Y Mandel, R Dalal, P Huie… – … Ophthalmology & Visual …, 2015

Animal facility. For surgeries, animals (P35–P50) were anesthetized with ketamine

(75 mg/kg) and Xylazine (5 mg/kg), delivered by intramuscular injection. Subretinal

implantations were performed as previously described. 31

 

[HTML] Following specific podocyte injury captopril protects against progressive long term renal damage

YS Zhou, IA Ihmoda, RG Phelps, COS Bellamy… – F1000Research, 2015

VD DOM02, made by Orion Pharma, supplied by Henry Schein Medical) and 100mg/ml

ketamine (Vetalar) (Ref. Terminal blood samples were collected at week 8 from intraperitoneally

anaesthetised animals (injected with medetomidine and ketamine).

 

Clinical Sedation Regimens

S Wilson – Oral Sedation for Dental Procedures in Children, 2015

Page 74. Clinical Sedation Regimens Stephen Wilson S. Wilson, DMD, MA, PhD

Division of Pediatric Dentistry, Department of Pediatrics, Cincinnati Children’s Hospital

Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229

 

Electrocardiogram reference intervals for clinically normal wild-born chimpanzees (Pan troglodytes)

R Atencia, L Revuelta, JD Somauroo, RE Shave – American Journal of Veterinary …, 2015

Immediately before the examination procedures, body weight was estimated.

Chimpanzees were anesthetized by administration of a combination of ketamine

hydrochloride a (5 mg/kg) and medetomidine b (50 μg/kg). Anesthetic

 

Deep Sedation and GA

SI Ganzberg – Oral Sedation for Dental Procedures in Children, 2015

When an anesthesia machine capable of delivering sevoflurane is not available, as is typical

is most dental offices,“induction” is most commonly provided with an intramuscular injection of

ketamine and midazolam with or without an anticholinergic, ie, such as glycopyr- rolate or

 

Radiofrequency Ablation (RFA)

 

In-utero radiofrequency ablation in fetal piglets: lessons learned

OO Olutoye, AN Gay, F Sheikh, AC Akinkuotu… – Journal of Pediatric Surgery, 2015

Methods 90 day gestation Yorkshire piglets (term 115 days) were subjected to RFA of the

chest and abdominal viscera under various temperatures and wattages. The extent of tissue

damage was determined by NADPH diaphorase histochemistry. Results Tyne

 

Strain echocardiographic assessment of left atrial function predicts recurrence of atrial fibrillation

SI Sarvari, KH Haugaa, TM Stokke, HZ Ansari, IS Leren… – Eur Heart J Cardiovasc …, 2015

Of these, 30 had not while 31 had recurrence of AF after radiofrequency ablation (RFA). Twenty

healthy individuals were included for comparison. For patients with symptomatic drug-refractory

AF, radiofrequency ablation (RFA) has become an important therapy option.

 

[HTML] Current management of patients with hepatocellular carcinoma

T Kanda, S Ogasawara, T Chiba, Y Haga, M Omata… – World J Hepatol, 2015

of HCC. Many HCC patients are treated with surgical resection and radiofrequency

ablation (RFA), although these modalities should be considered in only selected

cases with a certain HCC number and size. Although there

 

PP. 26.17: OUR CLINICAL EXPERIENCE WITH COMBINATION THERAPY OF OLMISARTAN AND AMLODIPINE IN THE TREATMENT OF RESISTANT …

T Chakalaa-Yancheva, S Tisheva, A Qnakieva… – Journal of Hypertension, 2015

In all patients MRA excluded new or progression of pre- existing low grade renal artery stenosis

as well as focal aneurysms at the sites of radiofrequency ablation. In none of the patients new

segmental perfusion deficits in either kidney were detected on MRI.

 

Multiscale Tetrahedral Meshes for FEM Simulations of Esophageal Injury

LA Neves, E Pavarino, MP Souza, CR Valencio… – Computer-Based Medical …, 2015

[3] OJ Eick and D. Bierbaum, “Tissue temperature- controlled radiofrequency ablation,” Pacing

and clinical electrophysiology, vol. [4] MO Siegel, DM Parenti, and GL Simon, “Atrialesophageal

fistula after atrial radiofrequency catheter ablation,” Clinical infectious diseases, vol.

 

The meaning of gross tumor type in the aspects of cytokeratin 19 expression and resection margin in patients with hepatocellular carcinoma

SC Gong, MY Cho, SW Lee, SH Kim, MY Kim, SK Baik – Journal of Gastroenterology …, 2015

From March 2012 to December 2014, 87 patients with HCC underwent surgical treatment including

intraoperative radiofrequency ablation at Wonju Severance Christian Hospital, Wonju, Korea.

Among them, 75 patients who underwent only hepatectomy were enrolled in

 

Impact of catheter ablation with remote magnetic navigation on procedural outcomes in patients with persistent and long-standing persistent atrial fibrillation

Q Jin, S Pehrson, PK Jacobsen, X Chen – Journal of Interventional Cardiac …, 2015

venous anatomy, left atrial (LA) volume, procedure time, mapping plus ablation time,

radiofrequency (RF) abla CFAEs at the right atrium were not mapped and ablated in this study.

Although PVAI and CFAE ablation time were calculat- ed separately, CFAE ablation time did

 

The role of AEG-1 in the development of liver cancer

CL Robertson, J Srivastava, D Rajasekaran, R Gredler… – Hepatic Oncology, 2015

by rapid growth and early vascular invasion and thus the incidence and mortality of the disease

run in parallel [1,3]. Standard treatment options for patients afflicted with localized forms of the

disease include surgical resection, radiofrequency ablation or liver transplantation [4–7

 

Unexpected Findings in the Left Atrium of a Patient with a Paravalvular Mitral Leak

FS Silva, CA Barreiros, MC Antunes, ÂL Nobre – Journal of Cardiothoracic and …, 2015

described including catheter-based cardiac interventions (eg valvular procedures, coronary

intervention, radiofrequency ablation), endocarditis, myocardial infarction and blunt cardiac

trauma.1 There are also cases of spontaneous dissection 2,10-11 occurring in patients with

 

[PDF] Typical chest pain and precordial leads ST-elevation in patients with pacemakers-are we always looking at an acute myocardial infarction?

MM Ostojić, TS Potpara, MM Polovina, MM Ostojić… – Vojnosanitetski pregled, 2015

ECG changes occurred due to pericardial re- action following two interventions: pacemaker

implantation a month before and radiofrequency catheter ablation of AV junction two weeks

before presentation in Emergency De- partment. Conclusion.

 

[PDF] AB10-06

RC ABLATION – Heart Rhythm, 2015

Methods: The clinical features including freedom from AF/atrial tachycardia (AT) recurrence

as outcome after RFCA were compared between women and men in 1: 1 age, AF type,

duration of AF (±1 year) matched manner. Subgroup analysis was performed in categories

 

MULTI-POLE SYNCHRONOUS PULMONARY ARTERY RADIOFREQUENCY ABLATION CATHETER

S Chen – US Patent 20,150,201,988, 2015

Abstract: A multi-pole synchronous pulmonary artery radiofrequency ablation catheter may

comprise a control handle, a catheter body and an annular ring. One end of the catheter

body may be flexible, and the flexible end of the catheter body may be connected to the

 

Diagnostic and Interventional Endoscopy

Y Tomizawa, I Waxman – Atlas of Esophageal Surgery, 2015

previous ablation zone. Ablation is repeated until the entire length of disease has

received radiofrequency energy (Fig. 3.15). After the entire lesion is ablated, the

guidewire, ablation catheter, and endoscope are removed. For focal

 

[HTML] Osteoid osteoma masquerading tubercular arthritis or osteomyelitis on MRI: Case series and review of literature

JP Singh, S Srivastava, D Singh – Indian Journal of Radiology and Imaging, 2015

periostitis. The patient underwent CT-guided biopsy and radiofrequency ablation. The

effusion. A CT-guided radiofrequency ablation (RFA) [Figure 10]C was performed and

the patient remained symptom-free at 20 months follow-up. Figure

 

Hybrid Transthoracic Esophagectomy

B Borraez, MG Patti – Atlas of Esophageal Surgery, 2015

hernia, 11, 12 Schatzki’s ring, 12, 13 sliding hiatal hernia, 10, 11, 46 squamous cell cancer, 19

Zenker’s diverticulum, 15, 97 Barrett’s esophagus esophagectomy, 151, 152 focal nodular lesion,

25, 27 proximal resection margin, 141, 147 radiofrequency ablation, 23, 29 salmon

 

PP. 26.16: CAN AN HOSPITAL ADMISSION MODIFY THE COURSE OF PATIENTS WITH RESISTANT HYPERTENSION?.

J Ribeiro, A Correia, R Ferreira, P Morgado, JM Bastos… – Journal of Hypertension, 2015

In all patients MRA excluded new or progression of pre- existing low grade renal artery stenosis

as well as focal aneurysms at the sites of radiofrequency ablation. In none of the patients new

segmental perfusion deficits in either kidney were detected on MRI.

 

Perspectives on the modern management of non-valvularatrial fibrillation: non-valvular af

R Gopal, MH Tayebjee – SA Heart, 2015

catheters and the development of balloon based or circular ablation catheters with multiple

ablation electrodes that can be applied to the pulmonary vein antrum to isolate pulmonary veins

and ablate left atrial substrate(44,17) (Figures 1 a,b,c). Both radiofrequency catheter and

 

APPARATUS AND METHODS FOR CLOSING VESSELS

BB Hill, J Hong, W Qi – US Patent 20,150,201,947, 2015

The following is a list of one or more advantages that may be achieved using the apparatus and

methods described herein, eg, as compared to endovenous laser, radiofrequency ablation

technologies, and other methods that destroy the vein by applying chemicals or applying

 

Fluorescence Imaging Systems (PDE, HyperEye Medical System, and Prototypes in Japan)

T Ishizawa, N Kokudo – Fluorescence Imaging for Surgeons: Concepts and …, 2015

 

Hepatocellular Carcinoma Precursor Lesions

ML Smith – Surgical Pathology of Liver Tumors, 2015

 

Chronic Regional Pain Syndrome (CRPS/RSD)

 

A scoring rule-based truthful demand response mechanism

K Hara, T Ito – Computer and Information Science (ICIS), 2015 IEEE/ …, 2015

Therefore, conventional scoring rule with single item, such as Brier score [5] is of no use for this

mode. In order to rightfully incentivize the CA to make their prediction of device shifting for multiple

items rightfully; the continuous ranked probability score (CRPS) is applied [13].

 

[PDF] Why Attackers Win: On the Learnability of XOR Arbiter PUFs

F Ganji, S Tajik, JP Seifert – 2015

These attacks, as cost-effective approaches, can clone the challenge-response behavior of an

arbiter PUF by collecting a subset of challenge-response pairs (CRPs). Moreover, when applying

current ML attacks, the maximum number of CRPs required for Page 3.

 

[PDF] A Multivariate Modeling Approach for Generating Ensemble Climatology Forcing for Hydrologic Applications

S Khajehei – 2015

Page 1. Portland State University PDXScholar Dissertations and Theses Dissertations and Theses

Spring 7-21-2015 A Multivariate Modeling Approach for Generating Ensemble Climatology Forcing

for Hydrologic Applications Sepideh Khajehei Portland State University

 

[HTML] Oil Palm Leaf and Corn Stalk–Mechanical Properties and Surface Characterization

Z Daud, MZM Hatta, H Awang – Procedia-Social and Behavioral Sciences, 2015

Bhaduri et al., 1995; BK Bhaduri, A. Day, SB Mondal, .SK Sen; Ramie hemicelluloses as beater

additive in a paper making from jute-stick kraft pulp. Industrial Crps and Products, 4 (1995), pp.

79–84. Daud et al., 2013; Z. Daud, MZM Hatta, ASM Kassim, AM Aripin, H. Awang;

 

[HTML] Nerve injury and neuropathic pain–a question of age

M Fitzgerald, R McKelvey – Experimental Neurology, 2015

Furthermore several complex pain syndromes (eg CRPS) that emerge in older children are

associated with little or no measurable disease activity or inflammation at the time of presentation

and are clinically defined as ‘functional’ or ‘medically unexplained’ (Bromberg et al

 

Acute acalculous cholecystitis and cardiovascular disease: a land of confusion

M Tana, C Tana, G Cocco, G Iannetti, M Romano… – Journal of Ultrasound, 2015

Most common clinical onset was represented by fever (70 %) in opposite to abdominal pain

which occurred in 20 % of patients. 8/10 patients were male. Elevated CRPs, leukocytosis

(60 %), and elevated aminotransferase (30 %) occurred frequently.

 

[PDF] Characterizing the Stability of Okun’s Law during Economic Recessions by cross-Recurrence Plot and Rolling Regression

J Gao, Y Cao

2 n xx x , , , and 1 2 n yy y , , , , which, for concreteness, may be equated to unemployment and

production data, one obtains CRPs (Marwan & Kurths 2002; Marwan, et al. 2007). 4, No. 3 ~ 5 ~

Figure 2. Cross recurrence plots (CRPs); notice the correspondence of vertical

 

[PDF] Use of Hidden Markov Mobility Model for Location Prediction and Biclustering for Cache Replacement in MANET

BD Shelar, MDK Chitre

But these policies give satisfactory performance for stable user and prove inefficient for mobile

user which free to change his direction. Direction and Distance Based CRPs think for the mobile

nature of user. Prediction Based CRPs analyze the history of users’ movements.

 

Field Deployable Chemical Redox Probe for Quantitative Characterization of Carboxymethylcellulose Modified Nano Zerovalent Iron

D Fan, S Chen, RL Johnson, PG Tratnyek – 2015

Page 1. 1 2 Field Deployable Chemical Redox Probe for Quantitative Characterization of 3

Carboxymethylcellulose Modified Nano Zerovalent Iron 4 5 6 Dimin Fan, Shengwen Chen, Richard

L. Johnson, and Paul G. Tratnyek* 7 8 Institute of Environmental Health 9

 

Technical innovations for small-scale producers and households to process wet cassava peels into high quality animal feed ingredients and aflasafe™ substrate

I Okike, A Samireddypalle, L Kaptoge, C Fauquet… – Food Chain, 2015

Headache and Pain

R Baron, A May – 2015

 

Molecular Biology of Retinoblastoma

SD Walter, JW Harbour – Recent Advances in Retinoblastoma Treatment, 2015

Rb directly inhibits E2Fs by binding and masking the transactivation domain, and it also recruits

chromatin remodeling proteins (CRPs) that alter local chromatin structure into a confirmation

that is not permis- sive for transcription.(b) When Rb is hyperphosphory- lated, it does

 

[PDF] Guidelines for Neuromusculoskeletal Infrared Thermography Sympathetic Skin Response (SSR) Studies

DO Getson, S Govindan, J Uricchio, T Bernton…

Assessment of patients with presumptive Complex Regional Pain Syndrome (CRPS) Type I or

II – formally known as Reflex Sympathetic Dystrophy (RSD), Thoracic Outlet Syndrome,

Vaso-motor Headache and Barre’-Leiou Syndrome. CRPS: Current Diagnosis and Therapy.

 

[HTML] Thread: Advances in treatment of post-amputation phantom limb pain

W Young, J Date

reviewed fifteen papers reporting mirror therapy to treat upper limb function and concluded that

most of the studies were weak methodologically and that the results suggest possible benefit

in patients after stroke and complex regional pain syndrome (CRPS) but the

 

[PDF] Guidelines For Dental-Oral And Systemic Health Infrared Thermography

M Brioschi, H Usuki, BSN Jan Crawford, P Steed…

c. Relevant risk factors for inflammation or vasomotor instability: prior history of RSD

or CRPS, trauma, fracture, repetitive use, vibration syndrome, peripheral neuropathy,

spinal pathology, radiculopathy, vasomotor headache, Page 4.

 

[HTML] Chronic Pain Medication & Treatment Guide

AR Guide

cord injuries. It may develop months or years after injury or damage to the CNS.

This also includes conditions such as chronic headaches, fibromyalgia, and Complex

Regional Pain Syndrome (CRPS). Tailoring selection of

 

[DOC] WORKSHOP ON BEST PRACTICE METHODS FOR ASSESSING THE IMPACT OF POLICY ORIENTED RESEARCH SUMMARY AND RECOMMENDATIONS FOR …

F Place, P Hazell

WORKSHOP ON BEST PRACTICE METHODS FOR ASSESSING THE IMPACT OF

POLICY ORIENTED RESEARCH. SUMMARY AND RECOMMENDATIONS FOR

THE CGIAR. Frank Place and Peter Hazell. WORKSHOP ON

 

CRPS A contingent hypothesis with prostaglandins as crucial conversion factor

PHE van der Veen – Medical Hypotheses, 2015

Abstract CRPS is an acute pain disease expressed as chronic pain with a severe loss of

tissue and function. CRPS usually occurs after minor injuries and then progresses in a way

that is scarcely controllable, or completely uncontrollable. This article addresses the

 

Vitamin C to Prevent Complex Regional Pain Syndrome in Patients With Distal Radius Fractures: A Meta-Analysis of Randomized Controlled Trials

N Evaniew, C McCarthy, YV Kleinlugtenbelt, M Ghert… – Journal of orthopaedic …, 2015

Collapse Box Abstract. Objective: To determine whether vitamin C is effective in preventing

complex regional pain syndrome (CRPS) in patients with distal radius fractures. 2 CRPS has been

previously referred to as causalgia, reflex sympathetic dystrophy, and algodystrophy. 3.

 

Injury of the corticoreticular pathway in patients with mild traumatic brain injury: A diffusion tensor tractography study

HD Lee, SH Jang – Brain Injury, 2015

Figure 1. Diffusion tensor tractography for the corticoreticular pathway (CRP): a normal control

subject (44 year-old, female), type A = the CRPs showed narrowing, although integrity was

preserved from the premotor cortex to the reticular formation of the medulla, type B = the

 

[PDF] Plasma Exchange Therapy in Patients with Complex Regional Pain Syndrome

E Aradillas, RJ Schwartzman, JR Grothusen, A Goebel – Pain Physician, 2015

Page 1. Background: Complex regional pain syndrome (CRPS) is a severe chronic

pain condition that most often develops following trauma. These patients were then

placed on Complex regional pain syndrome (CRPS) is a

 

Controversial Pain Syndromes of the Arm: Pathogenesis and Surgical Treatment of Resistant Cases

A Wilhelm – 2015

 

[PDF] Mixture EMOS model for calibrating ensemble forecasts of wind speed

S Baran, S Lerch – arXiv preprint arXiv:1507.06517, 2015

The most popular scoring rules are the logarithmic score, that is the negative logarithm of the

predictive PDF evaluated at the verifying observation and the continuous ranked probability score

(CRPS; Gneiting and Raftery, 2007; Wilks, 2011). CRPS(F, x) := ∫ ∞

 

[PDF] Targeted Ultrasound-Guided Double Catheters (Infraclavicular-Brachial Plexus, Median Nerve) Facilitate Hand Rehabilitation with Superb Analgesia and Motor …

AE Holman, B Sharma, VE Modest – Open Journal of Anesthesiology, 2015

http://creativecommons.org/licenses/by/4.0/ Abstract A 44-year-old male who suffered a

crush-degloving hand injury complicated by Complex Regional Pain Syndrome (CRPS) type

I was scheduled for operative hand manipulation and inpatient physi- otherapy.

 

Leads for neurostimulation and methods of assembling same

A Raines – US Patent 9,084,882, 2015

As used herein the term “complex regional pain syndrome” or “CRPS” refers to painful

conditions that usually affect the distal part of an upper or lower extremity and are

associated with characteristic clinical phenomena. CRPS

 

[PDF] Identification and characterization of a novel family of cysteine-rich peptides (MgCRP-I) from Mytilus galloprovincialis

M Gerdol, N Puillandre, G De Moro, C Guarnaccia… – Genome Biology and …, 2015

encoding peptides with unique chemico-physical properties and/or sequence patterns. Actually,

cysteine-rich peptides (CRPs) encompass a large and widespread group of secreted plants

(Gruber, et al. 2007; Marshall, et al. 2011; Taylor, et al. 2008). Invertebrate CRPs are

 

Peri‐infarct reorganization of an injured corticoreticulospinal tract in a patient with cerebral infarct

SH Jang, J Lee, HD Lee – International Journal of Stroke, 2015

(c) The CRPs are descended through the subcortical white matter in two age-matched normal

control subjects. Letter to the editor © 2015 World Stroke Organization E62 Vol 10, August 2015,

E62–E63 Page 2. References 1 Yeo SS, Chang MC, Kwon YH, Jung YJ, Jang SH.

 

Fibromyalgia

 

Depressive-like symptoms in a reserpine-induced model of fibromyalgia in rats

A Blasco-Serra, F Escrihuela-Vidal, EM González-Soler… – Physiology & Behavior, 2015

Abstract Since the pathogenesis of fibromyalgia is unknown, treatment options are limited,

ineffective and in fact based on symptom relief. A recently proposed rat model of

fibromyalgia is based on central depletion of monamines caused by reserpine

 

Is there any link between joint hypermobility and mitral valve prolapse in patients with fibromyalgia syndrome?

E Kozanoglu, IC Benlidayi, RE Akilli, A Tasal – Clinical Rheumatology, 2015

Abstract The objective of the present study is to determine whether benign joint

hypermobility syndrome (BJHS) modifies the risk of mitral valve prolapse (MVP) in patients

with fibromyalgia (FM). Female patients fulfilling the 1990 American College of

 

[HTML] Calibration and Validation of the Dutch-Flemish PROMIS Pain Interference Item Bank in Patients with Chronic Pain

MHP Crins, LD Roorda, N Smits, HCW de Vet… – PLOS ONE, 2015

as pain that persists beyond the normal tissue healing time, in which the most prevalent pain

is musculoskeletal pain, with prevalence varying from 30–40% for low back pain, 15–20% for

shoulder- and neck pain, 10–15% for chronic widespread pain and 2% for fibromyalgia [3,4

 

Assessment of response bias in neurocognitive evaluations

DA Carone – NeuroRehabilitation, 2015

survey data of neuropsychologists show that the base rates of malingering or symptom

exaggeration are much higher (29% to 41%) in settings where patients are seeking financial

compensation or disability and in patient groups (ie, concussion, fibromyalgia, chronic fatigue

 

[PDF] SENSE OF WELL-BEING IN PATIENTS WITH FIBROMYALGIA. AEROBIC EXERCISE PROGRAM IN A MATURE FOREST: A PILOT STUDY

S Lopez-Pousa, GB Pagès, S Monserrat-Vila

ABSTRACT Background and objective: Most patients with fibromyalgia benefit from different

forms of physical exercise. Studies show that exercise can help restore the body’s

neurochemical balance and that it triggers a positive emotional state. So, regular exercise

 

[HTML] Miller Chiropractic & Laser Treatment Center

D Emery

Acta Medica Academica 2013;42(1):46-54. doi: 10.5644/ama2006-124.70. Study Finds

Chiropractic Beneficial for Fibromyalgia. A new study from Egypt reports that chiropractic care

can be an effective treatment strategy for fibromyalgia treatment with chiropractic care.

 

[PDF] Cost-effectiveness of 40-hour versus 100-hour vocational rehabilitation on work participation for workers on sick leave due to subacute or chronic musculoskeletal …

TT Beemster, JM van Velzen, CAM van Bennekom… – Trials, 2015

as follows: 1) individuals of working age (18 to 65 years); 2) suffering from subacute (6 to 12 weeks)

or chronic (>12 weeks) nonspecific musculoskeletal pain such as back, neck, shoulder,

widespread pain, Whiplash Associated Disorder (WAD I or II), or fibromyalgia; 3) having

 

Peer-Reviewed Abstracts

D Avans – Research Quarterly for Exercise and Sport, 2015

Fine motor control knowingly declines with age and certain diseases such as fibromyalgia and

cerebral palsy (Perez-de-Heredia-Torres, 2013). Research of this nature could also be translated

to diseased populations such as those with fibromyalgia or diabetes.

 

Gastro-protective and Anti-stress Efficacies of Monomethyl Fumarate and a Fumaria indica Extract in Chronically Stressed Rats

A Shakya, UK Soni, G Rai, SS Chatterjee, V Kumar – Cellular and Molecular …, 2015

are some of the major symptoms of numerous, if not all, chronic inflammatory diseases

accompanying central sensitivity syndromes (Yunus 2008 ), and it is now well recognized that

cytokine and immune system abnormalities are the root cause of fibromyalgia and other central

 

[PDF] Mechanisms of action of balneotherapy in rheumatic diseases

A Fioravanti, S Cheleschi – IV CIBAP BOÍ 2015

Anti-inflammatory aspects Recent studies have shown a reduction of circulating levels of

Prostaglandin E2 (PGE2) and Leukotriene B4 (LTB4), important mediators of inflammation and

pain, in patients suffering from OA or fibromyalgia who undergo mud-packs or

 

Determinants of Patient Satisfaction in an Academic Rheumatology Practice.

JH Ku, A Danve, H Pang, D Choi, JT Rosenbaum – Journal of clinical rheumatology: …, 2015

95% CI, -15.25 to -3.25), arthralgia (β = -8.67; 95% CI, -16.60 to -0.74), myalgia (β = -8.67; 95%

CI, -16.60 to -0.74), gout (β = -7.5; 95% CI, -14.13 to -0.89), ankylosing spondylitis (β = -5.20;

95% CI, -9.65 to -0.75), pain (β = -4.62; 95% CI, -8.43 to -0.81), fibromyalgia (β = -4.62; 95

 

Method and Apparatus for Diagnosing and Assessing Centralized Pain

JB Hargrove – US Patent 20,150,201,879, 2015

Because of this emerging understanding, the role of CS is increasingly being shown to be

pathological in seemingly unrelated chronic pain conditions and syndromes including fibromyalgia,

complex regional pain syndrome, phantom pain, and migraine headaches.

 

FATTY ACID DERIVATIVES FOR USE IN A METHOD OF TREATING DEPRESSION AND ASSOCIATED CONDITIONS

E Berry, Y Avraham, J Katzhendler, J Mograbi… – US Patent 20,150,202,179, 2015

Abstract: The invention provides fatty acid derivatives for use in a method of treatment of at least

one disease, disorder or condition selected from anxiety, depression, conditions associated

menopause, stress, bipolar disorder, neuropathic pain and fibromyalgia.

 

ANTIBODIES TO IL-6 AND THEIR USES

A Rajpal, MN Devalaraja, K Toy, L Yang, H Huang… – US Patent 20,150,203,574, 2015

The term “fibromyalgia” is also known as fibromyalgia syndrome. The American College

of Rheumatology (ACR) 1990 classification criteria for fibromyalgia include a history

of chronic, widespread pain for more than three months

 

Impact of Gender-Based Aggression on Women’s Mental Health in Portugal

M Reis, L Ramiro, MG de Matos – … Mental Health: Resistance and Resilience in …, 2015

The rate was even higher for women who had experienced non-partner sexual violence (WHO,

2013). Health effects can also include headaches, back pain, abdominal pain, fibromyalgia,

gastrointestinal disorders, limited mobility, and poor overall health (WHO, 2013).

 

Pain 2014 Refresher Courses: 15th World Congress on Pain

SN Raja, CL Sommer – 2015

 

Restless Legs Syndrome: The Devil Is in the Details

PJ Sampognaro, RE Salas, A Kalloo, C Gamaldo – Sleepy or Sleepless: Clinical …, 2015

medical conditions Restless legs syndrome (Willis-Ekbom disease) Renal failure Periodic limb

movement disorder Anemia REM sleep behavior disorder (RBD) Peripheral neuropathy

Obstructive sleep apnea syndrome (OSAS) Rheumatoid arthritis Fibromyalgia Attention deficit

 

[PDF] Dermatologic Extrahepatic Manifestations of Hepatitis C

B Dedania, GY Wu – Journal of Clinical and Translational Hepatology, 2015

cutanea tarda23 – Lichen planus33,35,36 – Sicca syndrome – Auto-antibody productions

(rheumatoid factor, cryoglobulins, anti-smooth muscle) – Glomerulonephritis12 C. Possible

association2,16 – Polyarthritis – Pruritus – Fibromyalgia – Chronic polyradiculoneuropathy – Lung

 

PHOSPHATIDYLINOSITOL-3-KINASE C2 BETA MODULATORS AND METHODS OF USE THEREOF

E Skolnik, Z Li, S Srivastava – US Patent 20,150,204,846, 2015

Exemplary IgE-mediated allergic disorders include, without limitation, allergic rhinitis,

allergic or atopic asthma, anaphylaxis, atopic dermatitis, eczema, hay fever,

fibromyalgia, and an immediate type hypersensitivity reaction.

 

Psychological Interventions for the Management of Chronic Pain: a Review of Current Evidence

RS Kaiser, M Mooreville, K Kannan – Current Pain and Headache Reports, 2015

A few of the many variants of this approach will be highlighted. Currently, cognitive

behavioral therapy (CBT) is a first-line psychological treatment for individuals with chronic

pain, such as back pain, headache, arthritis, and fibromyalgia [ 12 •].

The Endless Search for Pain Relief

The Endless Search for Pain Relief

 F2.l

One constant throughout human history, unlimited by time or place, has been the search for pain relief. We have reached a point in the modern world where anesthetics, narcotics, over-the-counter pain relievers, etc., can give some measure of comfort in many painful situations. Yet, the search for improvement continues in neuroscience and pharmacology.

The discovery, in the 1840s, that ether and chloroform vapors could offer significant pain relief during surgery enabled development of the idea in the West that pain did not always have to be endured. Yet, a vast literature created over the centuries and around the world documents earlier, less successful efforts at pain relief. Contemporary research in ancient and medieval manuscripts continues to uncover medical practices from cultures around the world, including recipes for treatments of many types of pain.

Although published in 1946, Edgar S. Ellis’ book “Ancient Anodynes: Primitive Anaesthesia and Allied Conditions” is an excellent overview of the field. He covers pain relief by physical, psychological, inhalation and local methods. He cites many examples from the past: biological materials such as the poppy, belladonna, cannabis, hellebore, hemlock, garlic, curare and mandrake; various uses of alcohol; inhalation of different substances and mixtures; and snow or cold water.

One interesting effort that Ellis notes is the “sleeping apple,” a ball made of a mix of substances and described by authors ranging from the Roman physician Dioscorides in the first century ad to Italian scholar Giambattista della Porta in the 17th century. As he catalogs this enormous number of pain relief methods, Ellis often expresses his skepticism about their efficacy. Perhaps many had placebo value.

A method similar to the sleeping apple was the “soporific sponge,” or spongia somnifera. The sponge contained a mixture of herbals and was placed over the patient’s face or under the nostrils prior to surgery. Inhalation of the fumes allowed painless surgery while the patient was unconscious. Herbs used included poppy, hemp, henbane and mandragora.

Recipes for this method from the Arab world date back to the 11th century; others appeared in Italy, Germany and Spain into the 16th century. The earliest known example is from the Bamburg Antidotarium of the ninth century. This collection of medical recipes contains a very specific one for the sponge. Ingredients included an ounce of opium, eight ounces of mandrake leaf juice, three ounces of henbane juice, and green juice from hemlock. Mixed with an appropriate amount of water, this concoction soaked into a sponge that was allowed to dry. When needed, the sponge could be re-soaked in warm water for an hour, and was then ready to be placed under a patient’s nostrils for pain relief.

Sleeping potions of various kinds found their way into medieval and Renaissance literature, as well. Boccaccio’s “The Decameron,” Shakespeare’s “Othello” and “Antony and Cleopatra,” Marlowe’s “The Jew of Malta” and “The Arabian Nights,” among others, feature such plot devices. How widely they were actually used in medicine remains unknown. For instance, the great 16th-century French surgeon Ambroise Paré did not use any such pain-relieving methods. One would imagine that the spread of the recipe books throughout Europe during these centuries would have alerted physicians to the sponge and other pain relievers, if they had been truly effective.

In 1847, the Lancet published an abstract of an article by a French physician named Dauriol, who claimed to have used a sponge recipe to achieve surgical anesthesia. In 1888, British physician Benjamin W. Richardson used a mandrake–alcohol mix for experiments on pigeons, rabbits and his own lips, noting a gentle sleep in the animals—unless too high a dose produced death. Scopolamine and other alkaloids in the plant no doubt helped produce the effects that he noted.

Medical historian Plinio Prioreschi is a modern-day researcher who expressed skepticism about the sponge’s effectiveness in producing anesthesia for surgery, in a 2003 article in Medical Hypotheses.

In their research in Old and Middle English scientific and medical manuscripts, Linda Voigts and Patricia Kurtz found some 40 anesthetic recipes. Thirteen of them apparently had limited circulation due to what must have been recognized as their dangerous ingredients. However, they found 27 examples of a brief recipe for “a drynke that men callen dwale to make a man to slepe whyle men kerven him.”

In their book chapter, Voigts and Robert P. Hudson note that the word “dwale” could mean several things in Middle English: deception or delusion; a dazed or unconscious condition; a fool; the nightshade plant; or a soporific drink. The last meaning is used by Chaucer in “The Reeve’s Tale.”

The drink recipes are fairly consistent across the examples that the researchers found. Ingredients included swine gall, hemlock juice, wild nept, lettuce, poppy, henbane and vinegar. After boiling, the mixture could be stored until needed, after which three spoonfuls were to be mixed with a gallon of wine. The authors’ discussion of these ingredients, and the relationship of this recipe to others, is fascinating.

An example of a surgical anesthetic used in Japan well before 1846 has become well known in the West in recent decades. Seishu Hanaoka was a surgeon born in 1760 and died in 1835. Hanaoka improved herbal recipes for pain relief that came from China to the point where he was able to use the oral anesthetic in major surgeries.

His formula is known as Tsusensan: two main ingredients were mandarage of the Datura genus and Aconitum japonicum. The patient drank the hot liquid, and in two to four hours was ready for surgery. The effects lasted six hours or longer depending on the dose. Hanaoka left records of dozens of surgeries, including many for breast cancer. His illustrated “Surgical Casebook” is available on the U.S. National Library of Medicine’s website (www.nlm.nih.gov).

As with so many things, we tend to look at past efforts at pain relief with amusement. Yet, many of these recipes contained active ingredients recognized much later. Visitors from the past would no doubt be amazed at what we moderns can do to relieve pain, and they could easily appreciate our continuing efforts to find even better methods than we have now.

—A.J. Wright

 

Massive Research Project Targets Chronic Pain in the Military

Massive Research Project Targets Chronic Pain in the Military

Massive Research Project Targets Chronic Pain in the Military

 Screen Shot 2015-07-21 at 1.11.01 PM

Spanning five years, costing almost $22 million and spread across 13 separate research trials nationwide, several federal agencies are tackling head-on the mounting problem of how to treat chronic pain in the U.S. military without exacerbating the country’s opioid abuse problem.

The new research program, spearheaded by the National Institutes of Health’s National Center for Complementary and Alternative Medicine (NCCAM), the National Institute on Drug Abuse (NIDA) and the U.S. Department of Veterans Affairs (VA) Health Services Research and Development Division, will look at non-drug approaches for treating chronic pain and some of the conditions that go hand-in-hand with it, such as post-traumatic stress disorder (PTSD), drug abuse and sleep problems. Modalities to be studied will include, but are not limited to psychotherapy, bright light therapy and self-hypnosis. (See the table for a full list of the studies and lead investigators.)

Table. Chronic Pain Studies Focusing on the U.S. Military
Treatment Modality Conditions Lead Investigator (Institution)
Transcranial direct current stimulation and CBT combination therapy Chronic pain, opioid use, related health issues Jeffrey Borckardt, PhD (Medical University of South Carolina)
Morning bright light exposure Chronic low back pain, PTSD, mood, sleep Helen Burgess, PhD (Rush University Medical Center)
Use of mobile devices to display real-time brain activity to induce relaxation and pain relief PTSD, TBI Eric Elbogen, PhD (University of North Carolina)
Collaborative treatment model (chiropractic, primary care, mental health) Spine pain, related mental health conditions Christine Goertz, DC, PhD (Palmer College of Chiropractic)
Self-hypnosis, mindfulness meditation, education Chronic pain, poor QoL Mark Jensen, PhD (University of Washington, Seattle)
Novel approaches to EHRs Chronic pain Robert Kerns, PhD (Yale University)
Complementary/nonpharmacologic approaches Chronic pain Mary Jo Larson, PhD (Brandeis University)
Biofeedback, guided exercise, imagery, mindfulness meditation, CBT Opioid use in veterans with multiple traumatic injuries Donald McGeary, PhD (University of Texas Health Science Center)
Interactive mindfulness meditation Chronic pain Shari Miller, PhD (Research Triangle Institute)
Complementary/nonpharmacologic approaches Chronic Pain Melissa Polusny, PhD (University of Minnesota)
ACT Reduce postsurgical pain, opioid use due to preoperative stress Barbara Rakel, PhD (University of Iowa)
Cost-effectiveness of complementary and alternative medicine Musculoskeletal disorder–related pain and related conditions Stephanie Taylor, PhD (Sepulveda Research Corporation)
CBT, mindfulness-based relapse prevention Chronic pain–related substance abuse and misuse Kevin Vowles, PhD (University of New Mexico)
ACT, acceptance and commitment therapy; CBT, cognitive-behavioral therapy; EHRs, electronic health records; PTSD, post-traumatic stress disorder; QoL, quality of life; TBI, traumatic brain injury

The multicenter research effort, involving VA medical centers and academic institutions, will not only focus on active military and U.S. veterans, but will look at the effects on their families as well.

According to NCCAM director Josephine Briggs, MD, more Americans turn to complementary and alternative therapies for pain relief than for any other condition. That fact, and the need to stem the increasing problem of prescription painkiller abuse among military personnel, has led to the large-scale research effort, she said.

“The need for non-drug treatment options is a significant and urgent public health imperative,” Dr. Briggs said in a statement. “We believe this research will provide much-needed information that will help our military and their family members, and ultimately anyone suffering from chronic pain and related conditions.”

A recent large-scale study (N=2,597) showed that chronic pain among U.S. military following deployment was reported by 44% of study subjects, compared with 26% in the general population, and opioid use was seen in 15% versus 4%, respectively. Of individuals reporting chronic pain in the study, 65.6% described it as constant, and 51.2% stated that their pain was moderate or severe. Estimated costs related to chronic pain and its treatment in military personnel are close to $5 trillion (JAMA Intern Med 2014;174:1402-1403).

“Prescription opioids are important tools for managing pain, but their greater availability and increased prescribing may contribute to their growing misuse,” said Nora D. Volkow, MD, director of NIDA, in a statement. “This body of research will add to the growing arsenal of pain management options to give relief while minimizing the potential for abuse, especially for those bravely serving our nation in the armed forces.”

—Donald M. Pizzi

Complex Regional Pain Syndrome: Pathophysiology, Diagnosis, and Treatment

Complex Regional Pain Syndrome: Pathophysiology, Diagnosis, and Treatment

Complex Regional Pain Syndrome: Pathophysiology, Diagnosis, and Treatment

Screen Shot 2015-07-17 at 2.05.53 PM

Complex regional pain syndrome (CRPS) is a chronic, predominantly neuropathic and partly musculoskeletal pain disorder often associated with autonomic disturbances. It is divided into 2 types, reflecting the absence or presence of a nerve injury.

Patients with either type may exhibit symptoms such as burning pain, hyperalgesia, and/or allodynia with an element of musculoskeletal pain. CRPS can be distinguished from other types of neuropathic pain by the presence of regional spread as opposed to a pattern more consistent with neuralgia or peripheral neuropathy. Autonomic dysfunction (such as altered sweating, changes in skin color, or changes in skin temperature); trophic changes to the skin, hair, and nails; and altered motor function (such as weakness, muscle atrophy, decreased range of motion, paralysis, tremor, or spasticity) also can be present.1,2

At least 50,000 new cases of CRPS are diagnosed in the United States annually.1 Although the incidence rate is subject to debate, a large epidemiologic study from The Netherlands involving 600,000 patients suggests an incidence of 26.2 per 100,000 individuals. The study also found that women are 3 times more likely to be affected, with postmenopausal women having the greatest risk.3

Presentation

Type 1 CRPS, formerly known as reflex sympathetic dystrophy, often is triggered by a minor or major trauma—fractures account for about 60% of cases.2 Surgery is the next most common precipitating event at 20%. Other etiologies include injections, venipuncture, infections, burns, cerebrovascular accidents, or myocardial infarctions.2,4 There are no identifiable precipitating events in about 10% of patients.2

Type 2, formerly known as causalgia, often is related to high-velocity, blunt injuries, which make up more than 75% of cases. But any process that results in nerve injury, such as surgery, fractures, or injections, also can cause type 2 CRPS.4,5 More than 50% of type 2 cases involving the upper extremities often are related to injuries of the median nerve alone or in combination with another nerve of the upper extremity.5 About 60% of cases in the lower extremities are related to injury of the sciatic nerve.5 Almost all cases involve only partial nerve transection, with upper extremity involvement more prevalent than lower extremity.

Pathophysiology

Historically, CRPS has been poorly understood, and a lack of consistent diagnostic criteria often has been cited in literature. But research in recent years has provided substantial insight into the pathophysiology of the disorder.

As with many other complex conditions, the mechanisms involved in CRPS are multifactorial (Table 1) and include the peripheral and central nervous systems (Figure 1).1 Factors such as altered sympathetic and catecholaminergic function, peripheral and central sensitization, peripheral and central neurogenic inflammation, altered somatosensory representation in the brain, genetics, and psychology all affect patients to varying degrees.

Table 1. Summary of Pathophysiologic Mechanisms That May Contribute to CRPS1
Mechanism Supporting Pattern of Findings
Altered cutaneous innervation
  • Density of C- and Aδ-fibers in CRPS-affected region
  • Altered innervation of hair follicle and sweat glands in CRPS-affected limb
Central sensitization
  • Increased windup in CRPS patients
Peripheral sensitization
  • Local hyperalgesia in CRPS-affected vs unaffected extremity
  • Increased mediators of peripheral sensitization
Altered SNS function
  • Bilateral reductions in SNS vasoconstrictive function predict CRPS occurrence prospectively
  • Vasoconstriction to cold challenge is absent in acute CRPS but exaggerated in chronic CRPS
  • Sympatho-afferent coupling
Circulating catecholamines
  • Lower norepinephrine levels in CRPS-affected vs unaffected limb
  • Exaggerated catecholamine responsiveness because of receptor up-regulation related to reduced SNS outflow
Inflammatory factors
  • Increased local, systematic, and cerebrospinal fluid levels of proinflammatory cytokines, including TNF-α, IL-1β, -2, and -6
  • Decreased systemic levels of anti-inflammatory cytokines (IL-10)
  • Increased systemic levels of proinflammatory neuropeptides, including CGRP, bradykinin, and substance
  • Animal postfracture model of CRPS-1 indicates that substance P and TNF-α contribute to key CRPS features
Brain plasticity
  • Reduced representation of the CRPS-affected limb in somatosensory cortex
  • These alterations are associated with greater pain intensity and hyperalgesia, impaired tactile discrimination, and perception of sensations outside of the nerve distribution
Genetic factors
  • In the largest CRPS genetic study to date (150 CRPS patients), previously reported associations were confirmed between CRPS and HLA-related alleles
  • A TNF-α promoter gene polymorphism is associated with “warm CRPS”
Psychological factors
  • Greater preoperative anxiety prospectively predicts CRPS symptomatology after total knee arthroplasty
  • Emotional arousal has a greater effect on pain intensity in CRPS than in non-CRPS chronic pain, possibly via associations with catecholamine release
CGRP, calcitonin gene-related peptide; CRPS, complex regional pain syndrome; IL, interleukin; SNS, sympathetic nervous system; TNF, tumor necrosis factor

Screen Shot 2015-07-17 at 1.45.47 PM

Figure 1. Speculative model of interacting CRPS mechanisms.

CGRP, calcitonin gene-related peptide; CRPS, complex regional pain syndrome; IL, interleukin; TNF, tumor necrosis factor

Central Sensitization

Central sensitization is an increased firing of nociceptive fibers in response to intense or persistent noxious stimuli. It is mediated by the nociception-induced release of neuropeptides such as bradykinin, glutamate, and substance P. This phenomenon is part of the reason patients experience allodynia and hyperalgesia. It is not known whether central sensitization precedes, occurs with, or follows development of other CRPS signs and symptoms.1,4,6

Peripheral Sensitization

Peripheral sensitization occurs when an initial tissue trauma causes proinflammatory neuropeptides to be released from primary afferent fibers. These neuropeptides increase background firing of nociceptors, decrease the firing threshold for thermal and mechanical stimuli, and increase firing in response to nociceptive stimuli. This decrease in firing threshold contributes to patients experiencing allodynia and hyperalgesia.1,4,6

Sympathetic Nervous System

Several human studies demonstrated expression of adrenergic receptors on nociceptive fibers after nerve injury. Given that there is likely some sort of nerve damage in type 1 CRPS, this explains why sympathetic outflow has an important effect on pain in patients with this condition. Manipulations with whole-body cooling and heating have supported the theory of sympatho-afferent coupling, although it would not be correct to imply that altered sympathetic function is solely responsible for the development of CRPS. Vascular abnormalities seen in CRPS also are mediated by altered levels of endothelin-1, nitric oxide synthase, nitric oxide, and impaired endothelial-related vasodilatory function. During the progression from acute to chronic CRPS, patients have intense vasoconstriction response in the setting of lowered levels of norepinephrine, implying altered local sympathetic outflow. This is believed to occur due to up-regulation of noradrenergic receptors as a response to low levels of catecholamines. When patients experience pain or regular life stress, these sensitive receptors respond intensely to the release of catecholamines, resulting in a cold, blue, and sweaty appearance.1


Inflammation

The inflammatory process is involved in at least the acute phase of CRPS. There are 2 potential sources of inflammation:

  1. Classic mechanisms through actions of immune cells, which, after tissue trauma, secrete proinflammatory cytokines, including interleukin-1, -2, and -6, and tumor necrosis factor-α.
  2. Neurogenic inflammation, which occurs through the release of proinflammatory mediators directly from injured nociceptive fibers in response to various stimuli. These neuropeptides include substance P, calcitonin gene-related peptide, and bradykinin, which promotes plasma extravasation and local tissue edema.1

A subset of patients with CRPS has been found to have low levels of anti-inflammatory and high levels of proinflammatory cytokines.4

Autoimmunity

It has been suggested that autoantibodies may play a role in CRPS. Autoantibodies found in the plasma of patients with CRPS are active at the muscarinic cholinergic and β2 adrenoceptors. Transfer of serum immunoglobulin G to mice from patients with CRPS elicited symptoms of CRPS in recipient mice.7

Genetics

Although there is no clear evidence of genetic predisposition to developing CRPS, it would be prudent to further investigate genetic factors that influence inflammatory and other mechanisms contributing to the syndrome. The largest study of 150 CRPS patients has found a link between CRPS and HLA-related alleles.1,4

Psychological Factors

To date, no evidence has suggested a purely psychological form of CRPS. However, poor coping and emotional stress can certainly raise levels of circulating catecholamines, which could exacerbate vasomotor signs of CRPS, cause pain, and maintain central sensitization.1,4

Brain Plasticity

Functional magnetic resonance imaging scans have shown that there is significant cortical reorganization of somatosensory cortex, which may underlie various manifestations of CRPS. Functional disturbances in posterior parietal cortex responsible for integrating various external stimuli and constructing real-time body schema in space, also may contribute to chronification of pain.1,4,7

Diagnosis

The diagnosis of CRPS is clinical and depends on patient history, physical examination, and findings of musculoskeletal degeneration and secondary pain that develops as a result of persistence of the disease state. CRPS is a diagnosis of exclusion and cannot be made in the presence of other diagnoses that can be responsible for the presentation. Chronic CRPS needs to have symptoms and signs consistent with time-dependent effect of CRPS (ie, atrophy, dystrophy, contractions, and secondary pain).

In the initial several months of CRPS, hypoesthesia and hyperalgesia are common, whereas ongoing disease anesthesia dolorosa can be seen.2 The pain present in later cases when compared with the acute phase is more often present at rest and resistant to treatment. One of the hallmarks of persistent CRPS is the accumulation of orthopedic and neuropathic findings due to altered biomechanics of the affected area and tissue dystrophy and atrophy in superficial and deeper tissues, as well as development of secondary pain in the contralateral limb and other parts of the body as the patient attempts to compensate.

A main reason why CRPS is difficult to diagnose and treat is because the majority of patients do not have classic “warm” (acute) or “cold” (cold) affected limbs—they fall somewhere along the spectrum.1,4 Veldman et al described more patients as having the “cold” type as the duration of CRPS increases, however, some patients with CRPS for more than 10 years still have “warm” limbs.2 And despite being classified as 2 types, there is no evidence that pathophysiologic mechanisms or treatment responsiveness differ in any appreciable way except that type 2 and underlying nerve injury may need to be addressed directly, sometimes surgically (Figure 2).

Screen Shot 2015-07-17 at 1.46.51 PM

Figure 2. Schematic representation of treatment modalities based on pathophysiologic mechanisms.7

Skin biopsies of patients with type I CRPS show a significantly decreased amount of C and Aδ-fibers after tissue injury, possibly indicating nerve damage may be present in type 1.1 However, there is no clear evidence as to whether this is a cause or effect of CRPS. Animal models support an increased nociceptive firing in response to norepinephrine, providing evidence that there is sympatho-afferent coupling, which has been suggested by human studies.1 There is further suggestion in animal models that a transcription factor, nuclear factor-β, could play a role in CRPS. This may provide an upstream link between increased proinflammatory neuropeptides and increased proinflammatory cytokines in CRPS.1,4

It also has been shown that patients with CRPS and people with prolonged immobilization, from things like casts for limb fractures, show similar signs of edema, skin color changes, limited range of motion, and altered sensation. This suggests that patients with CRPS experience derangement of normal physiologic responses, making it difficult to identify when these physiologic changes becomes pathologic CRPS and not another diagnosis.4

Diagnostic Tools

During a consensus workshop in 1994, the International Association for Study of Pain (IASP) proposed diagnostic criteria based on clinical symptomatology (Table 2).8 Criticisms of the IASP criteria included a lack of specificity and misdiagnosing other types of neuropathic pain conditions as CRPS. The false diagnosis was thought to stem from the IASP criteria being met solely by self-reported symptoms uncovered by the history without physical signs and symptoms.7

Table 2. IASP CRPS Diagnostic Criteria8
CRPS I CRPS II
2-4 of the following with 2, 3, and 4 being mandatory:

  1. The presence of an initiating noxious event, or a cause of immobilization.
  2. Continuing pain, allodynia, or hyperalgesia with which the pain is disproportionate to any inciting event.
  3. Evidence at some time of edema, changes in skin blood flow, or abnormal sudomotor activity in the region of the pain.
  4. This diagnosis is excluded by the existence of conditions that would otherwise account for the degree of pain and dysfunction.
All of the following:

  • The presence of continuing pain, allodynia, or hyperalgesia after a nerve injury, not necessarily limited to the distribution of the injured nerve.
  • Evidence at some time of edema, changes in skin blood flow, or abnormal sudomotor activity in the region of the pain.
  • This diagnosis is excluded by the existence of conditions that would otherwise account for the degree of pain and dysfunction.
CRPS, complex regional pain syndrome; IASP, International Association for the Study of Pain

In an aim to improve the IASP criteria, an international consensus meeting was held in Budapest in 2003. The results were based on the previously published Harden/Bruehl criteria (Table 3).9 A 2010 study showed the IASP criteria of being 100% sensitive but only 41% specific in 113 CRPS type 1 patients and 47 non-CRPS neuropathic pain patients. The new Budapest criteria revealed 99% sensitivity with 68% specificity.10 Veldman’s criteria includes physical signs in combination with symptoms and was derived from a cross-sectional cohort study of 829 patients (Table 4).2

Table 3. Harden/Bruehl CRPS Diagnostic Criteria9
CRPS I
  1. Continuing pain, which is disproportionate to any inciting event
  2. Must report ≤1 symptom in 3 of the following 4 categories:
    • Sensory:
      Reports of hyperesthesia and/or allodynia
    • Vasomotor:
      Reports of temperature asymmetry and/or skin color changes and/or skin color asymmetry
    • Sudomotor/Edema:
      Reports of edema and/or sweating changes and/or sweating asymmetry
    • Motor/Trophic:
      Reports of decreased range of motion and/or motor dysfunction (weakness, tremor, dystonia) and/or trophic changes (hair, nails, skin)
  3. Must display ≤1 sign at time of evaluation in ≥2 of the following categories:
    • Sensory:
      Evidence of hyperalgesia (to pinprick) and/or allodynia (to light touch and/or temperature sensation and/or deep somatic pressure and/or joint movement)
    • Vasomotor:
      Evidence of temperature asymmetry (>1∞C) and/or skin color changes and/or asymmetry
    • Sudomotor/Edema:
      Evidence of edema and/or sweating changes and/or sweating asymmetry
    • Motor/Trophic:
      Evidence of decreased range of motion and/or motor dysfunction (weakness, tremor, dystonia) and/or trophic changes (hair, nails, skin)
  4. There is no other diagnosis that better explains the signs and symptoms
CRPS II
Same as CRPS I but with the evidence of a peripheral or central nerve injury
CRPS NOS
Patients who do not fully meet the clinical criteria, but whose signs and symptoms cannot be better explained by another diagnosis
CRPS, complex regional pain syndrome; NOS, not otherwise specified
Table 4. Veldman2 CRPS Diagnostic Criteria
CRPS I
  1. Presence of 4 or 5 of the following:
    • Unexplained diffuse pain
    • Difference in skin color relative to other limb
    • Diffuse edema
    • Difference in skin temperature relative to other limb
    • Limited active range of motion
  2. Occurrence or increase of above signs and symptoms after use.
  3. Above signs and symptoms are present in an area larger than the area of primary injury or operation and include the area distal to the primary injury.
CRPS, complex regional pain syndrome

Treatment

Although the majority of CRPS symptoms resolve within an approximate 12-month period, an estimated 25% of patients still fulfill IASP diagnostic criteria at 12 months and may suffer from CRPS chronicity. CRPS following fracture has a better resolution rate; “cold” CRPS or upper-limb involvement has the worst outcome. Because CRPS is a multifactorial disease with poorly understood mechanisms, the mainstay of treatment remains physical and occupational therapy aimed at return and preservation of function, prevention of loss of range of motion, and prevention of contractures and atrophy.4

Pharmacologic Treatment

IV Ketamine has proven to be very effective in the treatment of CRPS /RSD

At the Florida Spine Institute, treatment protocols are individually planned depending on the nature of pain and the patient’s responsiveness to initial sessions. Infusion cocktails are prepared in house so that they can be tailored to each patient’s therapeutic needs.  A variety of medications are often used:

  • Lidocaine
  • Ketamine
  • Bisphophonates
  • Magenesium

These medications are typically mixed with saline in an IV bag and infused slowly over several hours, depending on the medication and/or protocol being used.  Usually, a series of treatments will be recommended daily for a period of a week or more. The duration of pain relief following one or more ketamine infusions cannot be predicted. The goal is to achieve lasting relief as measured in weeks or months following the last treatment. Most patients who enjoy prolonged pain relief will need to return on occasion for a booster infusion, or continue to take low dose intranasal ketamine at home.

There is also convincing results with regard to IV bisphosphonates—most recently neridronate in patients with disease duration of less than 6 months. At 1-year follow-up, neridronate showed improved pain control. Multiple neuropathic medications such as gabapentin, tricyclic antidepressants, and opioids have been used through their extrapolated benefit in neuropathic conditions other than CRPS. Oral steroids continue to be used in acute CRPS, although the evidence is poor and sympatholytic drugs are used by clinicians with low success rates.7,11,12 But a recent small trial using low-dose oral phenoxybenzamine showed significant functional improvement in patients with CRPS.13 Taking everything above into consideration, we can conclude that the majority of pharmacologic treatments used by clinicians are quite empirical and largely based on personal preferences and experiences.

Interventional and Surgical Techniques

The main utility of interventional pain medicine in CRPS is to enable proper physical or occupational therapy and break the cycle of peripheral and/or central pain. Moderate evidence shows that sympathetic blockade is effective. Spinal cord stimulators appear to provide significant improvement of function in type 1 CRPS, and are more cost-effective over a patient’s lifetime compared with physical therapy and medical management.4,14 Although there is great resistance to surgery for CRPS patients, significant pain resolution may be achieved through nerve decompression or denervation procedures, neuroma resection, and neurolysis once patients are properly identified by nerve blocks. In many patients, the noxious stimulus is maintained through nerve compression; osteophytes; fibrosis; neuroma; arteriovenous malformation; or anything that entraps, compresses, or distorts the nerve. Surgery may be indicated in these cases.

Psychological Interventions

Psychological factors play a role in the treatment of CRPS. There is likely benefit in cognitive-behavioral therapy. Correcting body image also may help in CRPS affected patients.4,7

References

  1. Bruehl S. An update on the pathophysiology of complex regional pain syndrome. Anesthesiology. 2010;113(3):713-725.
  2. Veldman PH, Reynen HM, Arntz IE, et al. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet. 1993;342(8878):1012-1016.
  3. de Mos M, de Bruijn AGJ, Huygen FJPM, et al. The incidence of complex regional pain syndrome: a population-based study. Pain. 2007;129(1-2):12–20.
  4. Borchers AT, Gershwin ME. Complex regional pain syndrome: a comprehensive and critical review. Autoimmun Rev. 2014;13(3):242-265.
  5. Hassantash SA, Afrakhteh M, Maier RV. Causalgia: a meta-analysis of the literature. Arch Surg. 2003;138(11):1226-1231.
  6. Rockett, M. Diagnosis, mechanisms and treatment of complex regional pain syndrome. Curr Opin Anaesthesiol. 2014; 27(5):494-500.
  7. Gierthmühlen J, Binder A, Baron R. Mechanism-based treatment in complex regional pain syndromes. Nat Rev Neurol. 2014;10(9):518-528.
  8. Merskey M, Bogduk N, eds. Classification of chronic pain: descriptions of chronic pain syndromes and definition of pain terms; second edition. Seattle: WA; 1994.
  9. Harden RN, Bruehl S, Stanton-Hicks M, et al. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med. 2007;8(4):326-331.
  10. Harden RN, Bruehl S, Perez RS, et al. Validation of proposed diagnostic criteria (the “Budapest Criteria”) for complex regional pain syndrome. Pain. 2010; 150(2):268-274.
  11. Rowbotham, MC. Pharmacologic management of complex regional pain syndrome. Clin J Pain. 2006:22(5):425-429.
  12. O’Connell NE, Wand BM, McAuley J, et al. Interventions for treating pain and disability in adults with complex regional pain syndrome. Cochrane Database Syst Rev. 2013;4:CD009416.
  13. Inchiosa MA Jr. Phenoxybenzamine in complex regional pain syndrome: potential role and novel mechanisms. Anesthesiol Res Pract. 2013;2013:978615.
  14. Taylor RS, Van Buyten JP, Buchser E. Spinal cord stimulation for complex regional pain syndrome: a systematic review of the clinical and cost-effectiveness literature and assessment of prognostic factors. Eur J Pain. 2006;10(2):91-101.

 

Researchers Continue To Look for Basic Understanding of CRPS Causes

Researchers Continue To Look for Basic Understanding of CRPS Causes

Researchers Continue To Look for Basic Understanding of CRPS Causes
crps2

Researchers tasked with developing a rudimentary understanding of complex regional pain syndrome (CRPS) are dividing their attention in several different directions. According to several experts who spoke at the 2013 International Congress on Neuropathic Pain, there is evidence for inflammatory, neuropathic and immunologic roots to the enigmatic syndrome, and further investigation into these three aspects of the syndrome is necessary for the development of more effective treatments.

“These different contributing factors all influence each other, so we need to address all of them so that patients don’t get onto a downward spiral where each factor worsens another,” Anne Louise Oaklander, MD, PhD, associate neurologist at Massachusetts General Hospital and associate professor at Harvard Medical School, both in Boston, told Pain Medicine News after attending the panel discussion.

Not a Perfect Fit

Ralf Baron, MD, vice chair of the Department of Neurology and head of the Division of Neurological Pain Research and Therapy at the University Hospital Schleswig-Holstein in Kiel, Germany, told attendees that until recently, CRPS was understood to be clearly a neuropathic pain disorder. However, CRPS does not fit with the 2008 redefinition of neuropathic pain, defined as “pain arising as a direct consequence of a lesion or disease affecting the somatosensory system” (Neurology 2008;70:1630-1635).

CRPS is neuropathic in that there are characteristic neuropathic sensory abnormalities, but it also shows signs of central sensitization, inflammation, and autonomic and motor abnormalities,” Dr. Baron told attendees.

One way of grouping CRPS patients is by looking at their distinct somatosensory dysfunctions, Dr. Baron suggested. Individuals with deficits in temperature detection but no allodynia, and with loss of small nerve fibers, innervation and nerve degeneration, can be classified as having a neuropathic disorder. A second cluster of patients can be seen as having central sensitization, with normal temperature sensitivity but severe mechanical and thermal hyperalgesia. A third patient cluster may have inflammatory CRPS, with deep hyperalgesia and heat hyperalgesia but no hyperalgesia to prick testing, Dr. Baron explained.

An Autoimmune Disease?

Another way of understanding CRPS, proposed by Andreas Goebel, MD, PhD, senior lecturer and honorary consultant at the University of Liverpool and Walton Centre National Health Service Foundation Trust in Liverpool, United Kingdom, is that a subset of CRPS patients have an autoimmune disorder–related condition.

“It is possible that a regional immune response is triggered following stress, inflammation and trauma,” he posited.

Dr. Goebel believes some of the 15% of CRPS patients with refractory symptoms lasting longer than six to 12 months may fall into this group (Pain 2009;142:218-224). He noted that several studies support the autoimmune paradigm, with results showing that a subset of CRPS patients have elevated levels of serum antibodies to several bacterial pathogens.

“Furthermore, there is evidence for CRPS serum immunoglobulin binding to peripheral nerves,” he said (Neurology 2004;9:1734-1736).

Indeed, several small case series, including his own, have demonstrated the efficacy of intravenous immunoglobulin G (IgG) in subsets of patients with long-standing, refractory CRPS, Dr. Goebel said (Pain Med 2002;3:119-127). Additionally, a randomized controlled trial of 12 patients with long-standing CRPS who received the agent found that 25% had pain relief at least 50% relative to baseline and 17% had improvements in pain between 30% and 50% (Ann Intern Med 2010;152:152-158).

Although IgG has anti-inflammatory effects in addition to being an immunomodulator, Dr. Goebel believes IgG’s efficacy is likely not explained by its anti-inflammatory effect.

“All of the investigations which we have done, both in the lab and clinically, have been leaning more and more toward confirming there is an autoimmune aspect to CRPS,” Dr. Goebel concluded. “However, since we do not know which structures the autoimmune response is targeting, our current evidence remains somewhat indirect.”

According to Dr. Goebel, if some patients in fact have CRPS of autoimmune origin, “a range of potential therapies, such as therapeutic plasma exchange and B-cell modulating therapies, can be at our disposal.

“These have all been tried and tested in other autoimmune disorders, and we can have access to an armamentarium that we did not have before,” he said.

An “Ultralocal” Inflammatory Response?

Frank Huygen, MD, PhD, professor of anesthesiology at Erasmus Medical Center in Rotterdam, the Netherlands, argued the inflammatory component to CRPS could be the most clinically meaningful element of the syndrome in some patients. However, rather than looking for systemic inflammation, he believes researchers need to consider an “ultra-local” inflammatory response.

“There are inflammatory mediators that are increased in the blister fluid of an involved extremity in CRPS,” Dr. Huygen said.

His own research has documented increased levels of interleukin-6 and tumor necrosis factor (TNF)-alpha in some patients (Eur J Pain 2008;12:716-721).

In a small, placebo-controlled, randomized trial, Dr. Huygen and his colleagues showed that the anti-TNF drug infliximab (Remicade, Janssen) exacerbated symptoms in some CRPS patients, leading to discontinuation of the trial (Pain Pract 2013; May 22: doi: 10.1111/papr.12078). The researcher still believes there could be a role for infliximab and other biologics in the treatment of CRPS.

“Although the sponsor stopped the study early, preliminary data showed enormous reductions in TNF-alpha levels in blister fluid with infliximab treatment, but these did not correlate with clinical changes,” he said.

Summarizing the challenge of understanding and treating a complex syndrome, Dr. Baron suggested CRPS should no longer be seen monolithically as a neuropathic disorder.

“As long as we do not have a clearer pathophysiological picture of CRPS patients, and because of the obvious heterogeneity of the signs, symptoms and mechanisms of the syndrome,” he said, “it would be wise to look at the condition separately from other classical neuropathic pain syndromes.”

—David Wild

UA-56982048-1